Haschek and Rousseaux's Handbook of Toxicologic Pathology 2013
DOI: 10.1016/b978-0-12-415759-0.00027-3
|View full text |Cite
|
Sign up to set email alerts
|

Carcinogenicity Assessment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Indeed, administration of lersivirine to rats for up to 2 yr was associated with increases in neoplasms and related proliferative lesions in the expected target organs—liver and thyroid gland. Thus, the neoplastic and proliferative findings in the liver and thyroid gland in the 2-yr rat carcinogenicity study were attributed to the long-term effects of hepatocellular microsomal enzyme induction, associated hepatocellular hypertrophy (an adaptive response), and alteration of normal endocrine feedback mechanisms (Morton 2013; Zabka et al 2011). No microscopic findings or neoplasms in the pituitary gland related to administration of lersivirine have been observed in any studies conducted in rats, mice, and dogs.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, administration of lersivirine to rats for up to 2 yr was associated with increases in neoplasms and related proliferative lesions in the expected target organs—liver and thyroid gland. Thus, the neoplastic and proliferative findings in the liver and thyroid gland in the 2-yr rat carcinogenicity study were attributed to the long-term effects of hepatocellular microsomal enzyme induction, associated hepatocellular hypertrophy (an adaptive response), and alteration of normal endocrine feedback mechanisms (Morton 2013; Zabka et al 2011). No microscopic findings or neoplasms in the pituitary gland related to administration of lersivirine have been observed in any studies conducted in rats, mice, and dogs.…”
Section: Discussionmentioning
confidence: 99%